DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/l9btjg/2013_china) has announced the addition of the "2013 China Procedure Volumes Database" directory to their offering.
LSI forecasts a robust 9.8% CAGR* in China, with each individual medical market experiencing modest gains during the new forecast period.
Despite global and national economic headwinds, China continues to show strong growth in the healthcare industry. With the number of surgical procedures performed in 2013 exceeding 42 million, opportunities abound for manufacturers and investors looking for new revenue streams. This in-depth database has been updated to include current and forecast (2012-2017) surgical procedure volumes across 12 major medical segments in China.
Important Updates on Data:
- New Base Year
- New Forecasts, per Updated Drivers Below
- New Market Added, Now 12
Key Factors Driving Growth in China:
- Significant Demographic Shifts
- Rapidly Growing Elderly Population
- Shift in Disease Profile
- Changes in Urban v. Rural Population
Medical Segment Coverage:
- Aesthetic, Dermatological, Plastic Surgeries - 6.5% CAGR
- Cardiothoracic & Interventional Cardiology - 16.3% CAGR
- Ear, Nose, and Throat - 9.4% CAGR
- General Surgery - 7.6% CAGR
- Neurosurgery - 6.0% CAGR
- OB/GYN - 1% CAGR
- Ophthalmology - 5.8% CAGR
- Orthopedics - 16.1% CAGR
- Peripheral Vascular - 9.4% CAGR
- Spine - 16.7% CAGR
- Stereotactic Radiosurgery - 14.4% CAGR
- Urology - 1.5% CAGR
*Combined for majority of markets included.
For more information visit http://www.researchandmarkets.com/research/l9btjg/2013_china
